Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
18 Results for "
protease-cleavable
" in MedChemExpress (MCE) Product Catalog:
Products (18)
18 Results for "protease-cleavable" in MCE Product Catalog:
6
6 Publications Verification
Synonyms: MC-GGFG-DX8951
Research Areas:
MC-GGFG-Exatecan (MC-GGFG-DX8951) is a agent-linker conjugate for ADC. MC-GGFG-Exatecan is a DX8951 (a DNA topoisomerase I inhibitor) derivative with protease cleavable MC-GGFG linker. MC-GGFG-Exatecan shows antitumor activity and can be used to prepare DX8951 antibody conjugate (ADC) .
1
1 Cited Publications
Cat. No.: HY-P99016B
CAS No.: 1346452-25-2
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P99016A
CAS No.: 1346452-25-2
Cat. No.: HY-P1449
CAS No.: 187794-49-6
Target:
Research Areas:
Cat. No.: HY-132257
CAS No.: 1613313-09-9
Synonyms: SC-002
Target:
Research Areas:
Rovalpituzumab tesirine (SC-002) is an antibody-drug conjugate (ADC) with anticancer effects. Rovalpituzumab tesirine contains a DLL3-targeting antibody Rovalpituzumab (HY-P99043) tethered to a cytotoxic agent pyrrolobenzodiazepine by means of a protease-cleavable linker. Rovalpituzumab tesirine can be used for the stduy of small cell lung cancer (SCLC) .
Cat. No.: HY-P99683
CAS No.: 1629760-29-7
Synonyms: SGN-LIV1A
Target:
Research Areas:
Ladiratuzumab vedotin (SGN-LIV1A) is a LIV-1 targeting antibody drug conjugate (ADC) (IC50: 5.6 nM for LIV-1). Ladiratuzumab vedotin consists of humanized IgG1 monoclonal antibody, MMAE and a protease-cleavable linker. Ladiratuzumab vedotin can drive immunogenic cell death (ICD) to elicit an immune response. Ladiratuzumab vedotin can be used for research of breast cancer .
Cat. No.: HY-P3159
CAS No.: 1428885-83-9
Target:
Research Areas:
Cat. No.: HY-P99593
CAS No.: 1418200-58-4
Synonyms: DMUC5754A
Target:
Research Areas:
Cat. No.: HY-172287
CAS No.: 2845934-59-8
Target:
Research Areas:
DBCO-PEG2-Val-Cit-PAB-MMAE is an ADC linker featuring a DBCO group, a Val-Cit dipeptide, a PAB motif, and an MMAE warhead. The DBCO group is a click chemistry handle which readily reacts with azide groups, while the Val-Cit is a protease-cleavable dipeptide which releases the MMAE warhead into cells via an elimination mechanism.
Target:
Research Areas:
MC-GGFG-(7ethanol-10NH2-11F-Camptothecin) is a drug-linker conjugate for ADC, formed by conjugation of 7ethanol-10NH2-11F-Camptothecin (HY-156517) with the protease-cleavable MC-GGFG linker. MC-GGFG-(7ethanol-10NH2-11F-Camptothecin) is applicable for cancer research .
Cat. No.: HY-P99595
CAS No.: 1824663-83-3
Synonyms: AGS15E; ASG-15ME; 1vcMMAE
Target:
Research Areas:
Sirtratumab vedotin (ASG15-ME) is an ADC composed of a SLITRK6-specific human gamma 2 antibody (Igγ2) conjugated to a small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE) via a protease-cleavable linker .
Cat. No.: HY-P1449A
CAS No.: 2450273-39-7
Target:
Research Areas:
Cat. No.: HY-P991696
CAS No.: 3037532-60-5
Target:
Research Areas:
Cat. No.: HY-P3159A
Target:
Research Areas:
Cat. No.: HY-W800837
CAS No.: 2231240-82-5
Target:
Research Areas:
t-Boc-N-amido-PEG4-Val-Cit is a protease-cleavable ADC linker featuring a Boc-protected amine, a hydrophilic PEG spacer, and a Val-Cit dipeptide. The Val-Cit dipeptide is cleavable by cell proteases and features a carboxylic acid which is free for coupling reactions with amines to form amides. The Boc can be removed under acidic conditions to reveal a free primary amine, which may be used in a variety of reactions such as coupling or reductive amination.
Cat. No.: HY-185845
Target:
Research Areas:
MC-VC-PAB-PEG4-DBCO is a protease-cleavable ADC linker composed of Mc-VC-PAB and PEG4-DBCO moieties .
Cat. No.: HY-185492
CAS No.: 1799659-90-7
Research Areas:
MC-cBu-Cit-seco-CBI dimer (Compound 10) is a conjugate of an ADC drug toxin molecule and a linker, which consists of a DNA alkylating agent connected to a reactive maleimide via a protease-cleavable peptidomimetic linker .
Cat. No.: HY-P992166
Target:
Research Areas:
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
